1 / 6
Laboratory Research Material
NAD+
1000 mg per vial · Lyophilized powder
Laboratory Research Material
NAD+ 1000 mg per vial
$279.99
- Compound
- NAD+
- Amount per vial
- 1000 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Out of stock
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
NAD+ 1000 mg: research material
Buy NAD+ 1000 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme used in redox and other enzyme reactions. It is a nucleotide cofactor, not a peptide.
Choose the material and presentation
The plus sign identifies the oxidized cofactor; NADH is its reduced counterpart. NADP-related cofactors have an additional phosphate group. These distinctions matter when an assay specifies a particular cofactor. A precursor used to make NAD+ is also a different starting material from NAD+ itself.
Other presentations: NAD+ 500 mg.
NAD+ as a research cofactor
SIRT1 uses NAD+ in deacetylation reactions, making it one example of a cofactor-dependent enzyme system. Davenport and colleagues compared crystal structures of the human SIRT1 catalytic domain in open and closed states. The closed complex contained ADP-ribose, an NAD+ hydrolysis product, and a substrate-mimicking peptide. Their biochemical experiments also identified an inhibitory role for a C-terminal regulatory segment. This work explains enzyme organization and regulation; it does not measure cellular uptake of a purchased NAD+ preparation.
Product records and batch reports
Open the COA and documents tab for the available batch reports and product files. Match the product and lot, then read identity, purity and measured content as separate results.
Additional information
| CAS No. | 53-84-9 |
|---|---|
| Purity | ≥99% |
| Sequence | N/A (NAD+ is not a peptide) |
| Molecular Formula | C21H27N7O14P2 |
| Molecular Weight | 663.43 g/mol |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.